Capital Research and Management Company became a major shareholder in Amgen on June 25, 2025.
1 report, 0 independent
Updated Jun 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Capital Research and Management Company became a major shareholder in Amgen on June 25, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Capital Research and Management Company
American investment management company
Nothing else this week.
-
Amgen
American multinational biopharmaceutical company
Related events
- Amgen and Merck are currently competing against each other in the market for investor capital.
- Amgen Inc. trades on the NASDAQ stock exchange.
- Cantor Fitzgerald and other analyst firms issued ratings on Amgen stock, which is listed on the Nasdaq exchange.
- Both Amdocs and Amgen are currently subject to analyst reviews.
- Berkshire Hathaway disclosed a large share purchase of Amgen on September 22, 2026.
Coverage
Newest first; wire copies grouped- Unknown outlet